J.B. Chemicals & Pharmaceuticals Limited has established May 29, 2026, as the record date to determine shareholder eligibility for the final dividend for the financial year 2025-26. The announcement was made in compliance with Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The record date is essential for identifying the beneficial owners and shareholders entitled to receive the declared dividend. Only those shareholders listed in the company's records on this specific date will qualify for the payout.

Record Date Details

The following table outlines the key specifics regarding the corporate announcement:

Shareholders holding equity shares are advised to ensure their holdings are updated in the depository records to avail the dividend benefit. The company has requested the stock exchange to take this intimation on record.

J.B. Chemicals & Pharmaceuticals Limited has informed its shareholders that the 50th Annual General Meeting (AGM) of the company is scheduled to be held on June 17, 2026. The meeting will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM) at 3:00 p.m. IST, adhering to the provisions of the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In accordance with circulars issued by the Ministry of Corporate Affairs and SEBI, the electronic copy of the AGM notice and the annual report for the financial year 2025-26 will be sent to all shareholders whose email addresses are registered with the company or depository participants. These documents will also be accessible on the company's official website and the websites of BSE Ltd. and National Stock Exchange of India Ltd.

Shareholders who have not registered their email addresses are advised to do so to receive the communications and participate in e-voting. Those holding shares in physical mode must submit Form I-SR-1 and I-SR-2 along with a signed request letter and self-attested copies of their PAN card and address proof. Shareholders holding shares in dematerialised form should register or update their email details with their relevant depository participants.

For shareholders holding physical shares, the process to obtain User ID and Password for remote e-voting and e-voting during the AGM involves sending specific documents via email. Physical shareholders need to provide their name, folio number, scanned copies of the share certificate, PAN, and Aadhar. Demat shareholders must provide their name, DP ID-Client ID, client master or account statement, PAN, and Aadhar.

The company has encouraged shareholders to utilise the Electronic Clearing System (ECS) for receiving dividends. Demat shareholders are requested to register their bank details with depository participants, while physical shareholders must send a signed request letter to the Registrar and Transfer Agent (RTA) along with necessary forms and a cancelled cheque leaf. Shareholders with queries regarding participation or dividend payments may contact the company at investorrelations@jbpharma.com .